Respiratory Diseases Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
GILD	A	Gilead Sciences, Inc.	0.60
VRNA	B	Verona Pharma plc	-0.76
SPRY	B	ARS Pharmaceuticals, Inc.	3.15
VMD	B	Viemed Healthcare, Inc.	-3.72
ALVO	B	Alvotech	1.64
SMLR	C	Semler Scientific, Inc.	-9.07
TBPH	D	Theravance Biopharma, Inc.	-2.72
SVRA	D	Savara, Inc.	-0.14
AZN	F	Astrazeneca PLC	-2.31
MRK	F	Merck & Company, Inc.	-2.39

Symbol	Grade	Name	Weight
IWN	C	iShares Russell 2000 Value ETF	0.02
IWM	C	iShares Russell 2000 ETF	0.01
ITOT	B	iShares Core S&P Total U.S. Stock Market ETF	0.0
IWV	B	iShares Russell 3000 ETF	0.0
IWO	B	iShares Russell 2000 Growth ETF	0.0

Compare ETFs

Compare ITOT to IWO Compare IWN to IWM Compare IWN to IWV

Date	Stock	Title
Feb 7	VMD	(Exclusive) Stocks To Watch, PRO+ Edition
Oct 31	AZN	AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
Oct 31	MRK	Merck (MRK) Q3 2024 Earnings Call Transcript
Oct 31	MRK	Merck & Co., Inc. (MRK) Q3 2024 Earnings Conference Call Transcript
Oct 31	MRK	Merck & Co., Inc. 2024 Q3 - Results - Earnings Call Presentation
Oct 31	MRK	Merck Spooks Investors With A Guidance Cut In The Wake Of Light Diabetes, HPV Shot Sales
Oct 31	MRK	Merck narrows outlook; Keytruda drives Q3 beat despite Gardasil impact
Oct 31	MRK	Bristol Myers Squibb stock rises, Merck moves lower. Here's why.
Oct 31	GILD	Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It
Oct 31	MRK	Merck earnings top estimates amid solid demand for Keytruda cancer drug
Oct 31	AZN	3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
Oct 31	MRK	Merck in charts: KEYTRUDA continues to show an upward trend past 3 years, rises ~17% in Q3
Oct 31	MRK	Merck: Q3 Earnings Snapshot
Oct 31	MRK	Merck sees Gardasil China woes carrying into 2025
Oct 31	MRK	Merck Non-GAAP EPS of $1.57 in-line, revenue of $16.7B beats by $190M
Oct 31	MRK	Merck Announces Third-Quarter 2024 Financial Results
Oct 31	MRK	EVAX Exceeds Estimates and Confirms Partnership
Oct 31	GILD	AbTherx and Gilead Expand Collaboration on Innovative Antibody Discovery Technologies
Oct 31	AZN	China Widens AstraZeneca Probe as Country Boss Investigated
Oct 30	MRK	Merck Q3 Earnings Preview: Focus on Winrevair and Keytruda

Respiratory Diseases: Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.